Nature’s AI, led by Michael J. Cohen, Ed.D., Ph.D., today announced the launch of the UN International Sanity Resolution, a new initiative designed to help individuals and organizations address trauma, burnout, and mental illness from suicidal person and planet deterioration also known as ecocide.
Chemonics, a global leader in sustainable development, has partnered with Acumen Media to re-release its short documentary, Harnessing Tech for Sustainable Development, under the “SDG Leaders” series.
Electro Optic Systems Holdings Limited (“EOS”) (ASX: EOS) is pleased to announce that it has secured an order for a drone defence capability using a new 100kW high energy laser technology.
ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady, today announced that Xellera Therapeutics has been awarded a US$150,000 G-Rex® Grant to support the establishment of a highly efficient cGMP G-Rex® centric NK cell manufacturing platform NK cell therapies represent a rapidly growing segment in immuno-oncology, offering off-the-shelf treatment options for a wide range of solid tumors, hematologic malignancies, and viral infections.
Electro Optic Systems Holdings Limited (ASX:EOS) (OTCMKTS:EOPSY) today announces that it has secured an order for a drone defence capability based on a new type of high-power laser.
Following the mandatory 7-day post-launch waiting period, Skykraft has successfully completed the separation of our five Air Traffic Management (ATM) satellites launched on the 24th July aboard the TRACERS mission with SpaceX.
KAER Biotherapeutics Corporation, a biotechnology company based in Escondido, California, recently presented its novel aerosol delivery technologies at the Drug Delivery Summit (San Diego, February 2025) and the International Society of Aerosol in Medicine (ISAM) Congress (Washington, July 2025).
